Table 3

One-year clinical outcomes

	All regions n=35 389	Europe n=24 819	Asia n=6305	Africa/Middle East n=2081	South America/Mexico n=2184	P value
Target lesion failure†	3.2% (1135/35 389)	3.5% (867/24 819)	2.2% (137/6305)*	2.0% (41/2081)*	4.1% (90/2184)	<0.0001
Cardiac death†	1.3% (455/35 389)	1.3% (320/24 819)	0.9% (59/6305)*	0.9% (19/2081)	2.6% (57/2184)*	<0.0001
Target vessel MI†	0.9% (316/35 389)	1.1% (271/24 819)	0.4% (22/6305)*	0.6% (13/2081)*	0.5% (10/2184)*	<0.0001
Clinically driven TLR†	1.7% (591/35 389)	1.9% (458/24 819)	1.2% (78/6305)*	1.1% (22/2081)*	1.5% (33/2184)	<0.0001
All-cause death†	2.1% (746/35 389)	2.2% (539/24 819)	1.6% (101/6305)*	1.4% (28/2081)*	3.6% (78/2184)*	<0.0001
All MI†	1.2% (423/35 389)	1.5% (361/24 819)	0.4% (25/6305)*	1.1% (22/2081)	0.7% (15/2184)*	<0.0001
Revascularisations
TVR†	2.4% (830/35 389)	2.6% (655/24 819)	1.6% (100/6305)*	1.4% (28/2081)*	2.2% (47/2184)	<0.0001
TV non-TLR†	0.7% (261/35 389)	0.9% (226/24 819)	0.3% (17/6305)*	0.3% (6/2081)*	0.6% (12/2184)	<0.0001
TLR†	1.7% (614/35 389)	1.9% (469/24 819)	1.4% (86/6305)*	1.1% (23/2081)*	1.7% (36/2184)	<0.0001
Clinically driven revascularisations
TVR†	2.3% (800/35 389)	2.6% (638/24 819)	1.4% (91/6305)*	1.3% (27/2081)*	2.0% (44/2184)	<0.0001
TV non-TLR*	0.7% (252/35 389)	0.9% (218/24 819)	0.3% (16/6305)*	0.3% (6/2081)*	0.6% (12/2184)	<0.0001
Target vessel failure*	3.7% (1308/35 389)	4.1% (1016/24 819)	2.4% (148/6305)*	2.2% (46/2081)*	4.5% (98/2184)	<0.0001
Stent thrombosis†
Definite †	0.4% (146/35 389)	0.5% (125/24 819)	0.1% (9/6305)*	0.2% (4/2081)*	0.4% (8/2184)	<0.0001
Probable†	0.3% (94/35 389)	0.2% (60/24 819)	0.2% (13/6305)	0.2% (4/2081)	0.8% (17/2184)*	<0.0001
Definite/probable†	0.7% (238/35 389)	0.7% (183/24 819)	0.4% (22/6305)*	0.4% (8/2081)	1.1% (25/2184)*	<0.0001
Possible†	0.5% (190/35 389)	0.6% (141/24 819)	0.4% (23/6305)*	0.4% (8/2081)	0.8% (18/2184)	<0.0001
All bleedings	2.9% (1013/35 389)	3.7% (923/24 819)	0.6% (36/6305)*	0.7% (15/2081)*	1.8% (39/2184)*	<0.0001
BARC 2–5 bleeding	2.1% (743/35 389)	2.7% (675/24 819)	0.5% (29/6305)*	0.6% (12/2081)*	1.2% (27/2184)	<0.0001
BARC 3–5 bleeding	0.9% (304/35 389)	1.1% (265/24 819)	0.2% (14/6305)*	0.4% (8/2081)*	0.8% (17/2184)	<0.0001

Events are reported as % (n) in the patient population that reached 1-year follow-up, died during follow-up or who had event that contributed to the primary outcome measure (n=35 389). The p value is given for the comparison over all 4 regions.
Target lesion failure: composite of cardiac death, TV-MI or clinically driven TLR. Target vessel failure: composite of cardiac death, TV-MI or clinically driven TVR.
*Indicates a p value <0.05 for the difference in characteristics between the region as compared with Europe.
†Events were adjudicated by an independent Clinical Event Committee.
MI, myocardial infarction; TV non-TLR, target vessel but non-target lesion revascularisation; TLR, target lesion revascularisation; TVR, target vessel revascularisation.